Zobrazeno 1 - 10
of 28
pro vyhledávání: '"RM Parés"'
Autor:
V Charques Trallero, RM Parés Marimon, D Ferrandez Marti, M Camps Ferrer, J Serrais, A Retamero Delgado, S Mendiola
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Maintaining persistence is a key element in pharmacotherapy follow-up. Adverse effects of biosimilars may be one of the main causes for discontinuing treatment. Aim and objectives To analyse persistence as an effectiveness a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb69c2b2969cf12c7599f8c0f0f7b805
https://doi.org/10.1136/ejhpharm-2021-eahpconf.169
https://doi.org/10.1136/ejhpharm-2021-eahpconf.169
Autor:
RM Parés, D Ferràndez, M Medina, X Sanchez, J Serrais, Má Roch, A Retamero, C Salom, Mdle Galceran
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Despite the availability of international guidelines for antiemetic treatment in chemotherapy, their implementation during daily clinical practice is not optimal. Aim and objectives To assess adaptation of the antiemetic pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::850b5e7d47843852dac889d51c71c8de
https://doi.org/10.1136/ejhpharm-2020-eahpconf.321
https://doi.org/10.1136/ejhpharm-2020-eahpconf.321
Autor:
C Salom, RM Parés, X Sanchez, Má Roch, Mdle Galceran, D Ferràndez, M Medina, A Retamero, J Serrais
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Chemotherapy induced nausea and vomiting (CINV) remains an important adverse effect as it affects the quality of life of patients, implies chemotherapy dose reductions and compromises adherence. Aim and objectives To evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9b76611779818446fa9e4da2e15703a
https://doi.org/10.1136/ejhpharm-2020-eahpconf.320
https://doi.org/10.1136/ejhpharm-2020-eahpconf.320
Autor:
D Ferràndez, A Retamero, C Salom, J Bové, Grados, M Cucurell, AM Colquechambi, RM Parés, X Sanchez, J Serrais, S Sanchez
Publikováno v:
Eur J Hosp Pharm
Background According to recent literature, satisfaction with biologic treatment (BT) is quite high despite the risk of adverse events.1,2 Purpose To determine the degree of satisfaction among patients with rheumatologic and dermatological diseases tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9677fd95ecbace6c593a5683bfe57534
https://europepmc.org/articles/PMC7539393/
https://europepmc.org/articles/PMC7539393/
Autor:
D Ferrandez Marti, A Retamero Delgado, J Serrais Benavente, X Sanchez Fresquet, C Salom Garrigues, RM Parés Marimon
Publikováno v:
Eur J Hosp Pharm
Background Lactose is widely used as a filler in the manufacture of pharmaceutical tablets and capsules, which should be taken into account to avoid adverse effects in lactose-intolerant patients. Purpose A survey was conducted to find out the lactos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5fd6bf32445fd91f86795e2a998384c
https://doi.org/10.1136/ejhpharm-2018-eahpconf.472
https://doi.org/10.1136/ejhpharm-2018-eahpconf.472
Autor:
A Retamero Delgado, D Ferrandez Marti, X Sanchez Fresquet, RM Parés Marimon, CS alom Garrigues, Balaguer, V Gil, J Ventura, C Ollé, J Serrais Benavente
Publikováno v:
Patient safety and risk management.
Background Bae applied and evaluated between March and July 2016 by an expanded access to the drug, and the patients were followed until 15 October. Clinical data were obtained from the electronic history CernerMillenium and the variables were: age,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::522689810cd71ed4ea63cc6801ecdb01
https://doi.org/10.1136/ejhpharm-2017-000640.552
https://doi.org/10.1136/ejhpharm-2017-000640.552
Autor:
A Retamero Delgado, J Serrais Benavente, D Ferrandez Marti, RM Parés Marimon, C Salom Garrigues, X Sanchez Fresquet
Publikováno v:
Other hospital pharmacy topics.
Background Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. Clinical care for patients with HCV related liver disease has progressed considerably over the past years, thanks to improvements in pharmacolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fb73c320d849841e673111bc3a0ad6b
https://doi.org/10.1136/ejhpharm-2017-000640.416
https://doi.org/10.1136/ejhpharm-2017-000640.416
Autor:
C Salom Garrigues, C Campabadal Prats, J Serrais Benavente, M Balaguer Rovira, RM Parés Marimon, A Perelló Juncà, Y Cossio Gil, D Ferrandez Marti
Publikováno v:
European Journal of Hospital Pharmacy. 22:A181.3-A182
Background Benzodiazepines (BZP) in the elderly often have pharmacokinetic changes that could represent a potential risk of adverse effects. It is therefore recommended to avoid them or to reduce their usage time, if possible. Purpose To evaluate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5008c6c1b2e35ae21dbdfbab092b12ee
https://doi.org/10.1136/ejhpharm-2015-000639.445
https://doi.org/10.1136/ejhpharm-2015-000639.445
Autor:
J Serrais Benavente, RM Parés Marimon, A Perelló Juncà, D Ferrandez Marti, C Campabadal Prats, A Camacho Calvente
Publikováno v:
European Journal of Hospital Pharmacy. 21:A9.2-A10
Background A geriatric population with a high degree of comorbidity is more exposed to medicines-related problems. Purpose To evaluate the effect of a medicines revision group on medicines prescribing during the admission to a recently opened hospita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c292cb385bb0d3f73afa44e46d4ab26
https://doi.org/10.1136/ejhpharm-2013-000436.23
https://doi.org/10.1136/ejhpharm-2013-000436.23
Autor:
C Campabadal Prats, J Serrais Benavente, A Camacho Calvente, R Sala Robinat, D Ferrandez Marti, RM Parés Marimon, A Perelló Juncà
Publikováno v:
European Journal of Hospital Pharmacy. 20:A51.1-A51
Background Antiretroviral therapy (ART) has markedly decreased the morbidity and mortality due to HIV. However, toxicity, comorbidity and treatment failure, among others, may result in frequent initial ART regimen change. Purpose To identify and anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5249d2ac84b21bd045baf62c931f02da
https://doi.org/10.1136/ejhpharm-2013-000276.141
https://doi.org/10.1136/ejhpharm-2013-000276.141